Found 11 matching trials
Effects of GTS-21 on Smoking Behavior and Neurocognitive Functions
PHASE2Attempts to quit cigarette smoking are often accompanied by negative mood a...
Location
Multiple Locations
Nicotinic Agonist Effects on BMI and Neuronal Response
PHASE1Obesity is a serious and growing health problem in the United States. Obesi...
Location
University of Colorado
Nicotinic Receptors and Schizophrenia
PHASE2The investigators hypothesize that sustained-release DMXB-A-SR (3-2,4 dimet...
GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer's Disease
PHASE2A Double Blind, Placebo-Controlled Randomized Study to Compare the Safety a...
Nicotinic Receptors and Schizophrenia
PHASE1The study determines if a new preparation of a drug designed to treat schiz...
Location
VA Eastern Colorado Health Care System, Denver
Nicotinic Receptors and Schizophrenia
PHASE1This study proposes to conduct a clinical trial comparison of olanzapine an...
Location
VA Eastern Colorado Health Care System, Denver, CO
Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder
PHASE1This study will be a randomized, double-blind, placebo-controlled crossover...
Location
George Washington University Medical Center
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
PHASE2The study hypothesis is that 3-2,4 dimethoxybenzylidene anabaseine (DMXB-A)...
Location
VA Eastern Colorado Health Care System, Denver, CO
Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients
PHASE1This study will determine the effectiveness of a drug, dimethoxbenzylidene ...
Location
University of Colorado General Clinical Research Center
Anti-inflammatory Effects of GTS-21 After LPS
NARationale: The vagus nerve exerts an anti-inflammatory effect in in vitro a...
Location
Radboud University Nijmegen Medical Centre